Advertisement

Skin Cancer

Pembrolizumab Active in Mucosal Melanoma in KEYNOTE Studies

Three clinical trials of the immunotherapy pembrolizumab have shown that it is active against a rare subtype of skin cancer...

Prostate Cancer

Progress in Defining Molecular Signature for Aggressive Androgen-Indifferent Prostate Cancer

Prostate cancer has lagged behind breast cancer in the identification of predictive and prognostic biomarkers, but the field...

Solid Tumors

One Cycle of BEP as Good as Two in High-Risk Testicular Cancer

The approach to treatment of high-risk, clinical stage I, nonseminomatous or combined germ cell tumors...


Advertisement

More Top Stories

Kidney Cancer

Rana R. McKay, MD, on RCC: Continuing Benefit After Halting Treatment

Conquer Cancer Foundation Recognizes Global Oncology Researchers With International Innovation Grant

The Conquer Cancer Foundation (CCF) of ASCO recently announced the recipients of its 2017 International Innovation Grant. The 1-year grant of up to $20,000, given directly to each awardee’s nonprofit organization or government agency, funds research projects aimed at improving cancer care in low-...

Advertisement

Second Cancers May Be Deadlier in Pediatric, Adolescent, and Young Adult Patients

Second cancers in children as well as adolescents and young adults (AYAs) are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients aged 15 to 39 years overall, according to a new study by University of California (UC), Davis...

Kidney Cancer

Rana R. McKay, MD, on RCC: Continuing Benefit After Halting Treatment

Research Reveals New Treatment Possibilities for Prostate Cancer

Not all cancer research will result in a positive outcome for patients, but all research does provide information that continues to advance the treatment of cancer care. Recent clinical trials, including one funded in part by the Conquer Cancer Foundation (CCF) of ASCO, show that most prostate...

Lung Cancer

Stage I Lung Cancer: Treatment Advances Have Changed the Game

Read more in the Journal of Oncology Practice (JOP). Visit ASCOPubs.org/journal/jop Patients with stage I lung cancer are achieving excellent local tumor control, thanks to an evolution in radiotherapy and surgical approaches. Jeffrey A. Bogart, MD, Professor and Chair of the Department of...

FDA Grants Lorlatinib Breakthrough Therapy Designation for ALK-Positive Metastatic Non–Small Cell Lung Cancer

On April 27, the investigational next-generation ALK/ROS1 tyrosine kinase inhibitor lorlatinib was granted Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non–small cell...

Solid Tumors

Shridar Ganesan, MD, PhD, on Mutation Burden and Immunotherapy

Kristy L. Weber, MD, Named Second Vice President, AAOS Board of Directors

Orthopedic surgeon Kristy L. Weber, MD, became the second Vice President of the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors at the organization’s 2017 Annual Meeting. Her new role is the first position in a 4-year term of volunteer service that includes Dr. Weber serving as ...

Advertisement

New 'Bone-in Culture Array' Tests Therapies for Breast Cancer Metastasis

A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. Findings of this research were published by Wang et al in Nature Communications....


click me